General Information of the Compound
| Compound ID |
CP0576849
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(4R)-N-(1-acetylpiperidin-4-yl)-4-[(1S,2R,13S,14S,17R,18R)-7-acetyl-2,9,9,18-tetramethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]pentanamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C36H54N4O3
|
||||||||||||||||||
| Molecular Weight |
590.853
|
||||||||||||||||||
| Canonical SMILES |
C[C@H](CCC(=O)NC1CCN(CC1)C(C)=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C(C)(C)c5c(C[C@]4(C)[C@H]3CC[C@]12C)cnn5C(C)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C36H54N4O3/c1-22(8-13-32(43)38-26-15-18-39(19-16-26)23(2)41)28-10-11-29-27-9-12-31-34(4,5)33-25(21-37-40(33)24(3)42)20-36(31,7)30(27)14-17-35(28,29)6/h12,21-22,26-30H,8-11,13-20H2,1-7H3,(H,38,43)/t22-,27+,28-,29+,30+,35-,36-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
ZHBZKNYVLFSRML-YAXUPDDGSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound